Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Oct 30;12(10):1900-1907.
doi: 10.21037/tp-23-366. Epub 2023 Oct 27.

Chimeric antigen receptor T-cells in B-acute lymphoblastic leukemia: history, current situation, and future

Bradley J Muller  1   2 , Hiroto Inaba  1   2
Affiliations
Editorial

Chimeric antigen receptor T-cells in B-acute lymphoblastic leukemia: history, current situation, and future

Bradley J Muller et al. Transl Pediatr. .
No abstract available

Keywords: Chimeric antigen receptor T-cells (CAR T-cells); acute lymphoblastic leukemia (ALL); refractory; relapse.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: Both authors have completed the ICMJE uniform disclosure form (available at https://tp.amegroups.com/article/view/10.21037/tp-23-366/coif). HI reports that he received research support from Servier, Amgen, and Incyte, received consulting fees from Amgen, Servier, and Jazz Pharmaceuticals and honoraria from Amgen, and participated in the advisory board for Jazz Pharmaceuticals. BJM has no conflicts of interest to declare.

Figures

Figure 1
Figure 1
Structure of chimeric antigen receptor T-cells and mechanisms of action. The figure was created with the assistance of BioRender. CAR, chimeric antigen receptor; scFv, single-chain variable fragment; ALL, acute lymphoblastic leukemia.
See this image and copyright information in PMC

Comment on

References

    1. Inaba H, Pui CH. Advances in the Diagnosis and Treatment of Pediatric Acute Lymphoblastic Leukemia. J Clin Med 2021;10:1926. 10.3390/jcm10091926 - DOI - PMC - PubMed
    1. Hunger SP, Raetz EA. How I treat relapsed acute lymphoblastic leukemia in the pediatric population. Blood 2020;136:1803-12. 10.1182/blood.2019004043 - DOI - PubMed
    1. Inaba H, Pui CH. Immunotherapy in pediatric acute lymphoblastic leukemia. Cancer Metastasis Rev 2019;38:595-610. 10.1007/s10555-019-09834-0 - DOI - PMC - PubMed
    1. Cooper LJ, Topp MS, Serrano LM, et al. T-cell clones can be rendered specific for CD19: toward the selective augmentation of the graft-versus-B-lineage leukemia effect. Blood 2003;101:1637-44. 10.1182/blood-2002-07-1989 - DOI - PubMed
    1. Imai C, Mihara K, Andreansky M, et al. Chimeric receptors with 4-1BB signaling capacity provoke potent cytotoxicity against acute lymphoblastic leukemia. Leukemia 2004;18:676-84. 10.1038/sj.leu.2403302 - DOI - PubMed